George Pappas

Schedule 1 Therapeutics, Inc.

NIH Rank #5230
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#5,230
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 1 grant · National rank #5230.

Top grants by award amount

George Pappas's NIH grant portfolio, ranked by award amount.

  • 2R44DA051309-02A1R44
    Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics
    $2M
    award amount

Affiliation

Institutions that have administered grants for George Pappas.

Affiliated with Schedule 1 Therapeutics, Inc. (IL).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Schedule 1 Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #5230